Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis
Pharmaceutical Technology
OCTOBER 25, 2022
Pharmaceutical companies – and the FDA – are embracing FDCs. The potential to extend the patent life and market exclusivity of a company’s APIs is a potent financial incentive. Among the numerous advantages FDCs offer patients, physicians, and pharmaceutical companies, several are particularly noteworthy.
52 
Let's personalize your content